Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management

John Donald Marra, Filippo Frioni, Gessica Minnella, Monica Rossi, Tanja Malara, Silvia Bellesi, Elena Maiolo, Daniela Orteschi, Eugenio Galli, Andrea Bacigalupo, Livio Pagano, Simona Sica*, Gina Zini, Patrizia Chiusolo

*Corresponding author

Research output: Contribution to journalArticle

Abstract

A 70-year-old female patient with no known medical history presented in our ER with irradiating lumbar pain. CBC revealed moderate leukocytosis (WBC 25,000/mm3), severe thrombocytopenia (16,000/mm3), and moderate anemia (9.5 g/dL). Bone marrow (BM) aspirate (Fig. 1) revealed an infiltrate of blasts negative for myeloperoxidase (MPO) representing 65% of BM cellularity and trilineage dysplasia, compatible with a morphologic diagnosis of acute erythroid leukemia (AEL). Urgent molecular assays were positive for BCR/ABL1. The patient’s clinical conditions rapidly deteriorated, and despite maximal broad-spectrum antibiotics and vasopressors, the patient later succumbed to urosepsis in the ICU.
Original languageEnglish
Pages (from-to)N/A-N/A
JournalAnnals of Hematology
Volume103
Issue number3
DOIs
Publication statusPublished - 2024

All Science Journal Classification (ASJC) codes

  • Hematology

Keywords

  • Acute erythroid leukemia
  • BCR-ABL
  • Classification
  • TP53

Fingerprint

Dive into the research topics of 'Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management'. Together they form a unique fingerprint.

Cite this